Cargando…

Peripheral hepatic sinusoidal obstruction syndrome due to oxaliplatin‐based chemotherapy

Hepatic sinusoidal obstruction syndrome during oxaliplatin‐based chemotherapy has been shown to be associated with severe steatohepatitis. Gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging may identify various features of hepatic sinusoidal obstruction s...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Shinichiro, Okudaira, Sadayuki, Kobayashi, Kazuma, Kanetaka, Kengo, Eguchi, Susumu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389491/
https://www.ncbi.nlm.nih.gov/pubmed/30847217
http://dx.doi.org/10.1002/ccr3.1935
_version_ 1783397946152189952
author Kobayashi, Shinichiro
Okudaira, Sadayuki
Kobayashi, Kazuma
Kanetaka, Kengo
Eguchi, Susumu
author_facet Kobayashi, Shinichiro
Okudaira, Sadayuki
Kobayashi, Kazuma
Kanetaka, Kengo
Eguchi, Susumu
author_sort Kobayashi, Shinichiro
collection PubMed
description Hepatic sinusoidal obstruction syndrome during oxaliplatin‐based chemotherapy has been shown to be associated with severe steatohepatitis. Gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging may identify various features of hepatic sinusoidal obstruction syndrome, even when the lesion cannot be differentiated from sinusoidal obstruction syndrome by other imaging tools.
format Online
Article
Text
id pubmed-6389491
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-63894912019-03-07 Peripheral hepatic sinusoidal obstruction syndrome due to oxaliplatin‐based chemotherapy Kobayashi, Shinichiro Okudaira, Sadayuki Kobayashi, Kazuma Kanetaka, Kengo Eguchi, Susumu Clin Case Rep Clinical Images Hepatic sinusoidal obstruction syndrome during oxaliplatin‐based chemotherapy has been shown to be associated with severe steatohepatitis. Gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging may identify various features of hepatic sinusoidal obstruction syndrome, even when the lesion cannot be differentiated from sinusoidal obstruction syndrome by other imaging tools. John Wiley and Sons Inc. 2019-01-09 /pmc/articles/PMC6389491/ /pubmed/30847217 http://dx.doi.org/10.1002/ccr3.1935 Text en © 2018 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Images
Kobayashi, Shinichiro
Okudaira, Sadayuki
Kobayashi, Kazuma
Kanetaka, Kengo
Eguchi, Susumu
Peripheral hepatic sinusoidal obstruction syndrome due to oxaliplatin‐based chemotherapy
title Peripheral hepatic sinusoidal obstruction syndrome due to oxaliplatin‐based chemotherapy
title_full Peripheral hepatic sinusoidal obstruction syndrome due to oxaliplatin‐based chemotherapy
title_fullStr Peripheral hepatic sinusoidal obstruction syndrome due to oxaliplatin‐based chemotherapy
title_full_unstemmed Peripheral hepatic sinusoidal obstruction syndrome due to oxaliplatin‐based chemotherapy
title_short Peripheral hepatic sinusoidal obstruction syndrome due to oxaliplatin‐based chemotherapy
title_sort peripheral hepatic sinusoidal obstruction syndrome due to oxaliplatin‐based chemotherapy
topic Clinical Images
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389491/
https://www.ncbi.nlm.nih.gov/pubmed/30847217
http://dx.doi.org/10.1002/ccr3.1935
work_keys_str_mv AT kobayashishinichiro peripheralhepaticsinusoidalobstructionsyndromeduetooxaliplatinbasedchemotherapy
AT okudairasadayuki peripheralhepaticsinusoidalobstructionsyndromeduetooxaliplatinbasedchemotherapy
AT kobayashikazuma peripheralhepaticsinusoidalobstructionsyndromeduetooxaliplatinbasedchemotherapy
AT kanetakakengo peripheralhepaticsinusoidalobstructionsyndromeduetooxaliplatinbasedchemotherapy
AT eguchisusumu peripheralhepaticsinusoidalobstructionsyndromeduetooxaliplatinbasedchemotherapy